News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
227 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26337)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Drug Development
Idera Pharmaceuticals Presents Positive Translational and Clinical Data Update from Ongoing IMO-2125 Development Program at the 2017 Society for Immunotherapy of Cancer Annual Meeting (SITC)
These data will be presented at 4:45 P.M. E.T. on Saturday, November 11th.
November 9, 2017
·
8 min read
Drug Development
Immuron Successfully Completes NASH Phase II Clinical Study Milestone
The last patient in the Company’s NASH clinical study conducted the final scheduled visit on October 9, following a 28-week study period.
November 9, 2017
·
6 min read
Deals
PharMerica Announces Approval of Merger by Stockholders
The closing of the transaction remains subject to customary closing conditions.
November 9, 2017
·
5 min read
Genetown
Navitor Pharmaceuticals’ Scientific Founder Makes Seminal Discoveries Related to Role of Nutrient Sensors in mTOR Regulation and Activity
Today, Dr. Sabatini published in the journal Science the discovery of a new nutrient sensor in the mTORC1 pathway, SAMTOR
November 9, 2017
·
5 min read
Business
Stericycle, Inc. Announces Partnership With National Safety Council for Opioid Crisis Campaign
NSC has partnered with Stericycle, Inc. to launch a provocative nationwide campaign that will illustrate the faces behind the numbers, educate people on the scope of the problem and promote solutions to address the crisis.
November 9, 2017
·
3 min read
Pharm Country
NY-ESO Data Presented at the Connective Tissue Oncology Society (CTOS) Annual Meeting Confirm Potential of Adaptimmune’s SPEAR T-Cell Therapy
The company released updated data from the ongoing pilot study of NY‑ESO SPEAR T-cells in synovial sarcoma, as well as an overview of study design for the ongoing NY-ESO SPEAR T-cell trial.
November 9, 2017
·
5 min read
Business
Avenue Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
As of September 30, 2017, Avenue’s cash and short-term investments (certificates of deposit) totaled $26.1 million compared to $0.2 million at December 31, 2016, an increase of $25.9 million year-to-date.
November 9, 2017
·
6 min read
Business
Atara Biotherapeutics Announces Third Quarter 2017 Financial Results and Recent Highlights
Cash, cash equivalents and short-term investments as of September 30, 2017 totaled $200.2 million.
November 9, 2017
·
17 min read
Pharm Country
Tobii Pro Launches New Advancement in Eye Trackers for Behavioral Research
In conjunction with the initiation of the Spain clinical site, Abeona has established a local subsidiary to manage clinical trial and regulatory development efforts in Europe.
November 9, 2017
·
2 min read
Business
Sienna Biopharmaceuticals Reports Third Quarter 2017 Financial Results
Total operating expenses for the three months ended Sept. 30, 2017, were approximately $14.3 million.
November 9, 2017
·
1 min read
Previous
6 of 23
Next